Analytical validation of an mRNA-based urine test to predict the presence of high-grade prostate cancer
The challenge for prostate cancer (PCa) diagnosis is to improve the ability to distinguish indolent from aggressive PCa. Increased urinary levels of Distal-less Homeobox 1 (DLX1) and Homeobox C6 (HOXC6) mRNA have...
Translational Medicine Communications 2017 2:5
Published on: 11 May 2017